Physician
Retina Consultants PC
Retina Consultants PC was paid $25.78M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 71% of everything it billed.
33Billing provider infoRETINA CONSULTANTS PC
MANCHESTER, CT 06042
MANCHESTER, CT 06042
33aNPI1093748071assigned 07/10/2006
33bProvider typeOphthalmology Physician
28Total paid$25.78M
24GClaims244,185
24DCodes billed29
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Connecticut
Rank by total paid#1 of 97
Median peer was paid$13K
This provider vs. median1,915×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,694 | $2.55M | |
| 2019 | 24,822 | $3.15M | |
| 2020 | 21,269 | $3.11M | |
| 2021 | 34,581 | $3.79M | |
| 2022 | 41,499 | $4.16M | |
| 2023 | 49,625 | $4.71M | |
| 2024incomplete | 48,695 | $4.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 71% | 36,113 | 20,428 | $18.22M |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 8.1% | 4,442 | 2,093 | $2.08M |
| 67028 | Intravitreal injection of a pharmacologic agent | 6.0% | 48,227 | 28,891 | $1.55M |
| J2778 | Injection, ranibizumab, 0.1 mg | 5.2% | 2,750 | 2,183 | $1.33M |
| 92250 | 2.1% | 19,570 | 15,844 | $543K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.6% | 31,744 | 23,638 | $415K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.6% | 20,379 | 16,180 | $402K |
| 92134 | 1.4% | 49,132 | 34,947 | $349K | |
| 67228 | <1% | 1,309 | 873 | $157K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 3,034 | 2,524 | $154K |
| J3590 | Unclassified biologics | <1% | 311 | 144 | $116K |
| 92235 | <1% | 2,922 | 2,444 | $101K |
17 more codes
| 92226 | <1% | 9,427 | $88K | |
| J0177 | Injection, aflibercept hd, 1 mg | <1% | 153 | $73K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,368 | $42K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 914 | $28K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | <1% | 117 | $26K |
| 92202 | <1% | 10,186 | $25K | |
| 67210 | <1% | 128 | $24K | |
| J0179 | Injection, brolucizumab-dbll, 1 mg | <1% | 39 | $13K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 254 | $11K |
| 76512 | <1% | 136 | $6K | |
| 92225 | <1% | 423 | $6K | |
| 92020 | <1% | 388 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 52 | $3K |
| 92201 | <1% | 517 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 104 | $815.67 |
| 76510 | <1% | 33 | $667.36 | |
| 99072 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEARY, LISA (OFFICE MANAGER)